宫颈再次注射吲哚菁绿提高子宫内膜癌前哨淋巴结检出率
该回顾性研究纳入251例子宫内膜癌患者,在机器人辅助分期手术中行前哨淋巴结活检。首次注射后双侧检出率为73.3%,对67例双侧未检出者中51例行宫颈再次注射,双侧检出率提升至94.5%。宫颈再次注射ICG可显著提高前哨淋巴结检出率,减少侧特异性淋巴结清扫。
要点
- 首次注射ICG后双侧SLN检出率为73.3%(184/251)。
- 对双侧未检出者行宫颈再次注射后,双侧检出率升至94.5%(222/235)。
- 再次注射可减少不必要的侧特异性淋巴结清扫。
核心结论
- 宫颈再次注射ICG在双侧SLN映射失败时显著提高检出率,减少侧特异性淋巴结清扫。
研究设计与样本
- 回顾性队列研究,纳入2016年6月至2020年4月连续251例子宫内膜癌患者,均行机器人辅助分期手术及SLN活检。
主要发现
- 首次注射后双侧检出184例(73.3%),单侧57例(22.7%),未检出10例(4.0%)。
- 67例双侧未检出者中51例行宫颈再次注射,再次注射后双侧检出率94.5%(222/235),单侧5.1%(12/235),未检出0.4%(1/235)。
临床怎么用
- 机器人辅助子宫内膜癌分期术中,若首次ICG注射后双侧SLN未检出,可考虑行宫颈再次注射以提高检出率。
局限性
- 回顾性研究设计,存在选择偏倚可能;单中心数据,外部推广需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the role of cervical re-injection of indocyanine green (ICG) to increase the detection rate of sentinel lymph node (SLN) in patients with endometrial cancer (EC) who underwent robotic-assisted surgical staging. METHODS: We retrospectively identified consecutive EC patients undergoing robotic-assisted staging with SLN biopsy at our Institution between June 2016 and April 2020. Patients were excluded if they had open abdominal surgical approach, neoadjuvant chemotherapy, and advanced stage [International Federation of Gynecology and Obstetrics (FIGO) stage III-IV] at diagnosis. According to our SLN protocol, in case of either unilateral or no SLN detection, we performed an ipsilateral or bilateral cervical re-injection of ICG. RESULTS: In total, 251 patients meeting inclusion criteria were included in the analysis. At first injection, bilateral detection was achieved in 184 (73.3%), unilateral detection in 57 (22.7%), and no detection in 10 (4.0%) patients. Cervical re-injection was performed in 51 of 67 patients with failed bilateral mapping. After cervical re-injection, bilateral detection rate increased to 94.5% (222/235), while unilateral and no detection were 5.1% (12/235) and 0.4% (1/235), respectively. CONCLUSIONS: Our results suggest that cervical re-injection of ICG, in case of failed bilateral mapping of SLN, brings about a significant improvement in SLN detection rates, therefore reducing the number of side-specific required lymphadenectomies.
引用
- Maramai M, Achilarre MT, Aloisi A, et al. Cervical re-injection of indocyanine green to improve sentinel lymph node detection in endometrial cancer. Gynecol Oncol. 2021. PMID: 33906784. doi:10.1016/j.ygyno.2021.04.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。